[Checkpoint inhibitor-induced myocarditis] / Sjekkpunkthemmerindusert myokarditt.
Tidsskr Nor Laegeforen
; 142(18)2022 12 13.
Article
in Nor
| MEDLINE
| ID: mdl-36511752
ABSTRACT
Immunological checkpoint inhibitors have been revolutionary in the treatment of cancer. A rare but serious adverse effect is the development of heart muscle inflammation (myocarditis). The prevalence of this type of myocarditis is increasing as more cancer patients receive treatment with immune checkpoint inhibitors. Knowledge of immune checkpoint inhibitor-induced myocarditis is important to enable early diagnosis and initiation of treatment. In this article we provide a clinical review of this.
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Drug-Related Side Effects and Adverse Reactions
/
Myocarditis
/
Neoplasms
Type of study:
Diagnostic_studies
/
Risk_factors_studies
/
Screening_studies
Limits:
Humans
Language:
Nor
Journal:
Tidsskr Nor Laegeforen
Year:
2022
Type:
Article